BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantAH
Andreessen Horowitz (a16z)
Activity from announced rounds
Activity in this selectionBiotech
Andreessen Horowitz invests in technology companies from seed through growth, with specialist teams in AI, enterprise software, infrastructure, fintech, crypto, healthcare and consumer technology.
The firm pairs investors with an operating platform spanning recruiting, marketing, legal matters and public policy. This structure gives a founder access to specialists for building a management team, reaching customers and navigating regulated markets alongside the investment relationship.
Its American Dynamism practice extends the mandate into areas such as defence and industrial technology. Founders should identify the relevant investing practice: a16z operates across several markets with different technical and commercial requirements.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $127M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionThird Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosed